Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Operating activities:
Net income	$ (20,496)	$ (2,295)
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation	997	1,018
Recovery of doubtful accounts	0	(1)
Non-cash interest expense	7,369	0
Loss/(Gain) on disposal of property and equipment	0	(103)
Stock-based compensation	427	215
Changes in operating assets and liabilities:
Restricted cash -NY Lottery and Purse Accounts	(823)	(722)
Accounts receivable	341	(220)
Prepaid expenses and other current assets	(1,609)	(2,075)
Other assets	68	127
Accounts payable	(762)	250
Accrued expenses and other current liabilities	1,238	(491)
Net cash (used in) provided by operating activities	(13,250)	(4,297)
Investing activities:
Purchases of property and equipment	(632)	(713)
Restricted cash - Racing capital improvement	2	57
Project development costs	0	(3,212)
Net cash used in investing activities	(630)	(3,868)
Cash flows from financing activities:
Proceeds from rights issue, net	13,180	11,178
Series E preferred shares redemption	0	(1,528)
Proceeds from exercise of stock options	2,389	0
Net Cash Provided by (Used in) Financing Activities	15,569	9,650
Net (decrease) increase in cash and cash equivalents	1,689	1,485
Cash and cash equivalents, beginning of period	7,526	9,063
Cash and cash equivalents, end of period	9,215	10,548
Supplemental disclosures of cash flow information:
Interest paid	999	999
Non-cash investing and financing activities:
Common stock issued in settlement of preferred stock dividends	218	205
Project development costs included in accrued expenses	$ 0	$ 950